[1] Björnsson ES, Bergmann OM, Björnsson HK, et al. Incidence, presentation, and outcomes in patients with drug- induced liver injury in the general population of Iceland. Gastroenterology, 2013, 144: 1419-1425.
[2] Chalasani NP, Hayashi PH, Bonkovsky HL, et al. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug - induced liver injury. Am J Gastroenterol, 2014, 109:950-966.
[3] 中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南.中华肝脏病杂志,2015,23:810-820.
[4] Danan G, Benichou C. Causality assessment of adverse drug reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol, 1993, 46: 1323-1330.
[5] Teschke R, Wolff A, Frenzel C, et a1. Drug and herb induced liver injury: council for international organizations of medical sciences scale for causality assessment. World J Hepatol, 2014, 6: 17-32
[6] Padda MS, Sanchez M, Akhtar AJ, et al. Drug- induced cholestasis. Hepatology, 2011, 53: 1377-1387.
[7] Fontana RJ. Pathogenesis of idiosyncratic drug - induced liver injury and clinical perspectives. Gastroenterology, 2014, 146: 914-928.
[8] 于乐成,陈成伟. ACG特异质性药物性肝损伤临床诊治指南解读. 肝脏,2014,19: 570- 574.
[9] Zyoud SH, Awang R, Sulaiman SA. Reliability of the reported ingested dose of acetaminophen for predicting the risk of toxicity in acetaminophen overdose patients. Pharmacoepidemiol Drug Saf, 2012,21:207-213.
[10] 温祝杜,胡国信,郑洁,等.药物性肝损伤168例临床分析. 广西医学,2016,38:574-576+580.
[11] 周云,张丽媛,何晶,等.抗结核药物致药物性肝炎与体质量的关系. 海南医学,2018,29:1146-1147.
[12] Lee WM. Drug-induced hepatotoxicity. N EnglJ Med, 1995, 333: 1118-1127.
[13] 张平,柯玉满,樊小春,等.药物性肝损伤临床分析324例. 世界华人消化杂志,2013,21:3720-3723.
[14] 李瑞,宋育林,任晓非,等.药物性肝损伤的临床特点及其预后评估. 安徽医药,2017,21:1106-1110.
[15] 徐琴,刘浩,张跃新.药物性肝损伤患者的回顾性分析122例. 世界华人消化杂志,2016,24:3177-3181. |
